Skip to content

Korea
World
Technology
Business
Sports
Entertainment
Health

Korea
World
Technology
Business
Sports
Entertainment
Health

Boehringer

Boehringer Ingelheim, the largest investment in R&D last year in Corona 19

Boehringer Ingelheim, the largest investment in R&D last year in Corona 19

Boehringer Ingelheim inhaled corona antibody treatment, year-end emergency approval application

Boehringer Ingelheim inhaled corona antibody treatment, year-end emergency approval application

200 efficacy compared to Boehringer Ofeb

200 efficacy compared to Boehringer Ofeb

footer

Contact Us
Sitemap
News-Sitemap

© 2025 Aju.News/en